NAMSA Revenue and Competitors
Estimated Revenue & Valuation
- NAMSA's estimated annual revenue is currently $470.6M per year.
- NAMSA's estimated revenue per employee is $251,000
Employee Data
- NAMSA has 1875 Employees.
- NAMSA grew their employee count by 1% last year.
NAMSA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate VP | Reveal Email/Phone |
2 | Chief Information Officer | Reveal Email/Phone |
3 | Associate VP, Corporate Finance | Reveal Email/Phone |
4 | Associate VP, North American Laboratory Services | Reveal Email/Phone |
5 | Associate VP, Scientific Affairs | Reveal Email/Phone |
6 | VP, Global Quality & Regulatory Compliance, Engineering, & Environmental Health & Safety | Reveal Email/Phone |
7 | SVP, Global Laboratory Operations | Reveal Email/Phone |
8 | VP, HR & Integration | Reveal Email/Phone |
9 | General Counsel and Corporate Secretary | Reveal Email/Phone |
10 | VP Global Marketing and Commercial Operations | Reveal Email/Phone |
NAMSA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 55 | -15% | $1.3M | N/A |
What Is NAMSA?
NAMSA is a multinational company specializing in nonclinical testing to determine the safety and effectiveness of medical devices. NAMSA also manufactures sterilization monitoring products, biological and chemical indicators.
keywords:N/A
N/A
Total Funding
1875
Number of Employees
$470.6M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NAMSA News
Cigniti, NAMSA, TÜV SÜD, MET Labs, Eurofins, Intertek, Exova, Charles River, BDC Laboratories, QualiTest, Element, Emergo, CPT Labs, Noble Life Sciences,...
Engaging NAMSA as strategy advisors to develop and apply proven medical device reimbursement strategies is a huge advantage for Endonovo...
TOLEDO, Ohio & DIEST, Belgium--(BUSINESS WIRE)--NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global...
TOLEDO, Ohio--(BUSINESS WIRE)--Mar 11, 2021-- NAMSA®, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its executive leadership transition plan with the appointment of Dr. Christophe Berthoux as NAM ...
TOLEDO, Ohio--(BUSINESS WIRE)--Mar 11, 2021-- Please replace the release with the following corrected version due to multiple revisions in the fourth paragraph. The updated release reads: NAMSA BEGINS NEXT CHAPTER OF GROWTH UNDER NEWLY APPOINTED CEO, DR. CHRISTOPHE BERTHOUX NAMSA®, the world ...